Nomogram for predicting the risk of gastroesophageal varices after primary endoscopic prophylaxis for variceal hemorrhage in patients with cirrhosis

Background and aims The aim of this study was to identify predictors of non-high-risk gastroesophageal varices and evaluate the probability of the residual high-risk varices in cirrhosis patients after the primary endoscopic treatment. Patients and methods Medical records of the patients with cirrhosis admitted for primary endoscopic prophylaxis gastroesophageal varices hemorrhage were retrospectively analyzed. The patients were divided into high-risk varices and non-high-risk varices groups according to the endoscopy. A nomogram was developed based on the results of multivariate Cox analyses. Accuracy of this model was validated by the concordance index (Harrell’s c-index) and calibration curve. Results Altogether 117 patients were enrolled between March 2014 and April 2018. The multivariate Cox analyses identified spleen length <140 mm [odds ratio (OR) = 2.715; P = 0.037), small or medium size of esophageal varices (OR = 4.412; P = 0.017), unaccompanied with gastric varices (OR = 7.025; P = 0.003) and frequency of endoscopic variceal ligation ≥one time per 4 months (OR = 3.834; P = 0.034) as independent factors of non-high-risk varices. All significant predictors were incorporated into a nomogram to predict the residual high-risk varices, which showed a notable accuracy with the concordance index (0.833). Conclusion The nomogram-based prediction of residual high-risk varices can be used for risk stratification in cirrhosis patients with gastroesophageal varices.

[1]  R. Marinho,et al.  Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study , 2019, Liver international (Print).

[2]  K. Patel,et al.  Noninvasive Predictors of High-Risk Varices in Patients with Non-Cirrhotic Portal Hypertension , 2019, Canadian journal of gastroenterology & hepatology.

[3]  M. Abecassis,et al.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2019, Clinical Liver Disease.

[4]  S. Baik,et al.  Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score , 2018, Journal of cachexia, sarcopenia and muscle.

[5]  E. Dajti,et al.  A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease. , 2018, Journal of hepatology.

[6]  Christopher U. Jones,et al.  Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  G. Burazeri,et al.  Predictors of esophageal varices and first variceal bleeding in liver cirrhosis patients , 2017, World journal of gastroenterology.

[8]  Zhongheng Zhang,et al.  Drawing Nomograms with R: applications to categorical outcome and survival data. , 2017, Annals of translational medicine.

[9]  J. Hoofnagle,et al.  Noninvasive markers for staging fibrosis in chronic delta hepatitis , 2017, Alimentary pharmacology & therapeutics.

[10]  J. Bosch,et al.  Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases , 2017, Hepatology.

[11]  J. Bosch,et al.  Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” study , 2016, Hepatology.

[12]  A. Kahraman,et al.  Spleen and Liver Stiffness Is Positively Correlated with the Risk of Esophageal Variceal Bleeding , 2016, Digestion.

[13]  J. Jang,et al.  Comparison of hepatic venous pressure gradient and endoscopic grading of esophageal varices. , 2016, World journal of gastroenterology.

[14]  X. Qi,et al.  Diagnostic Accuracy of APRI, AAR, FIB-4, FI, and King Scores for Diagnosis of Esophageal Varices in Liver Cirrhosis: A Retrospective Study , 2015, Medical science monitor : international medical journal of experimental and clinical research.

[15]  L. Eusebi,et al.  Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature , 2015, European journal of gastroenterology & hepatology.

[16]  R. de Franchis Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. , 2015, Journal of hepatology.

[17]  A. Sanyal,et al.  Invasive and non-invasive techniques for detecting portal hypertension and predicting variceal bleeding in cirrhosis: A review , 2014, Annals of medicine.

[18]  Sang Gyune Kim,et al.  The Risk Factors for Bleeding of Fundal Varices in Patients with Liver Cirrhosis , 2013, Gut and liver.

[19]  R. Orlando,et al.  Splenomegaly as risk factor of liver cirrhosis. A retrospective cohort study of 2,525 patients who underwent laparoscopy. , 2011, In vivo.

[20]  J. Bosch,et al.  Management of varices and variceal hemorrhage in cirrhosis. , 2010, The New England journal of medicine.

[21]  M. Tarzamni,et al.  Portal hemodynamics as predictors of high risk esophageal varices in cirrhotic patients. , 2008, World journal of gastroenterology.

[22]  N. Mattek,et al.  Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database. , 2007, Gastrointestinal endoscopy.

[23]  T. Savides,et al.  Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices. , 2005, Gastroenterology.

[24]  C. Ng,et al.  Diagnostic value of Doppler assessment of the hepatic and portal vessels and ultrasound of the spleen in liver disease , 2004, European journal of gastroenterology & hepatology.

[25]  G. Iconomou,et al.  Non-invasive predictors of the presence of large oesophageal varices in patients with cirrhosis. , 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[26]  A. Burroughs,et al.  Prevention of variceal rebleeding , 2003, The Lancet.

[27]  D. Jensen Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. , 2002, Gastroenterology.

[28]  A. Gatta,et al.  Role of spleen enlargement in cirrhosis with portal hypertension. , 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[29]  L. Bolondi,et al.  Influence of the Spleen on Portal Haemodynamics: a Non-invasive Study with Doppler Ultrasound in Chronic Liver Disease and Haematological Disorders , 2002, Scandinavian journal of gastroenterology.

[30]  P. Hayes,et al.  Current endoscopic therapeutic options in the management of variceal bleeding , 2001, Alimentary pharmacology & therapeutics.

[31]  P. Bedossa,et al.  Non-invasive diagnosis of esophageal varices in chronic liver diseases. , 1999, Journal of hepatology.

[32]  A. Zaman,et al.  Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease , 1999, American Journal of Gastroenterology.

[33]  P. Hsu,et al.  Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: a prospective, randomized trial. , 1999, Journal of hepatology.

[34]  A. Burroughs,et al.  Primary prevention of bleeding from esophageal varices. , 1999, The New England journal of medicine.

[35]  K. Ota,et al.  Risk factors for hemorrhage from gastric fundal varices , 1997, Hepatology.

[36]  S. Sarin,et al.  Prevalence, classification and natural history of gastric varices: A long‐term follow‐up study in 568 portal hypertension patients , 1992, Hepatology.

[37]  E. Ancona,et al.  Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. , 1988, The New England journal of medicine.